Patent details

EP2672970 Title: FORMS OF RIFAXIMIN AND USES THEREOF

Basic Information

Publication number:
EP2672970
PCT Application Number:
US2012024746
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP127453728
PCT Publication Number:
WO2012109605
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FORMS OF RIFAXIMIN AND USES THEREOF
French Title of Invention:
FORMES DE RIFAXIMINE ET LEURS UTILISATIONS
German Title of Invention:
FORMEN VON RIFAXIMIN UND ANWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
10/02/2012
Grant date:
01/08/2018
EP Publication Date:
18/12/2013
PCT Publication Date:
16/08/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/08/2018
EP B1 Publication Date:
01/08/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
10/02/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/07/2018
 
 

Name:
Salix Pharmaceuticals, Ltd.
Address:
8510 Colonnade Center Drive, Raleigh, NC 27615, United States (US)

Agent

Name:
Dennemeyer & Associates - Validation Department
From:
01/08/2018
Address:
P.O. Box 1502, 1015, Luxembourg, Luxembourg (LU)
To:

Inventor

1

Name:
McQUEEN, Lisa
Address:
United States (US)

2

Name:
ANDRES, Patricia
Address:
United States (US)

3

Name:
DING, Fei
Address:
United States (US)

4

Name:
PARENT, Stephan
Address:
United States (US)

5

Name:
SMIT, Jared P.
Address:
United States (US)

6

Name:
WU, Yiduo
Address:
United States (US)

7

Name:
SCHIELDS, Paul
Address:
United States (US)

Priority

1

Priority Number:
201161441902 P
Priority Date:
11/02/2011
Priority Country:
United States (US)

2

Priority Number:
201161530905 P
Priority Date:
18/10/2011
Priority Country:
United States (US)

3

Priority Number:
201161556649 P
Priority Date:
07/11/2011
Priority Country:
United States (US)

4

Priority Number:
201261583024 P
Priority Date:
04/01/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4375; A61P 1/00; C07D 498/22;

Publication

European Patent Bulletin

Issue number:
201831
Publication date:
01/08/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/03/2027
Annual Fee Number:
16
Annual Fee Amount:
230 Euro
Expected Payer:
Last Annual Fee Payment Date:
29/01/2026
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
02/08/2018 Outgoing Correspondence 1
01/08/2018 Power Of Attorney 2